West Roxbury, MA, United States of America

Nicholos Mitsiades

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholos Mitsiades. Retrieved from https://idiyas.com/inventor/nicholos-mitsiades

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicholos Mitsiades: Innovator in Tumor Cell Growth Inhibition

Introduction

Nicholos Mitsiades is a prominent inventor based in West Roxbury, MA (US). He has made significant contributions to the field of cancer research, particularly in the area of tumor cell growth inhibition. His innovative work has the potential to impact the lives of many individuals battling cancer.

Latest Patents

Nicholos holds 1 patent for his invention titled "Methods for inhibiting tumor cell growth." This patent describes methods that utilize an insulin-like growth factor receptor inhibitor to inhibit tumor cell growth in subjects in need of such treatment. His research is crucial in developing new therapeutic strategies for cancer patients.

Career Highlights

Nicholos Mitsiades is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in oncology. His work at this esteemed institution allows him to collaborate with leading experts in the field and contribute to groundbreaking studies.

Collaborations

Nicholos has worked alongside notable colleagues, including Andrew L. Kung and Constantine S. Mitsiades. These collaborations enhance the research efforts and foster innovation in cancer treatment methodologies.

Conclusion

Nicholos Mitsiades is a dedicated inventor whose work in tumor cell growth inhibition represents a significant advancement in cancer research. His contributions are vital for the ongoing fight against cancer, and his innovative methods hold promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…